Bright Minds Biosciences (DRUG) Metrics: History & Chart

Bright Minds Biosciences Inc.(DRUG)

Biotechnology · New York, NY

$49.03-0.76 (-1.53%)

Delayed quote: Oct 6, 2026, 11:34 AM EDT

About Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatric and neurology indications; and BMB-105, a 5-HT2C agonist to treat Prader Willi Syndrome. Bright Minds Biosciences Inc. has a collaboration with Firefly Neuroscience, Inc. to provide an analysis of the electroencephalogram (EEG) data in the Company’s BREAKTHROUGH study. The company was founded in 2017 and is headquartered in New York, New York.

New York, NY

26 employees

www.brightmindsbio.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Ian McDonald

View full financials

Third-Party DCF Estimate (FMP)	$8.32
Price Gap vs Third-Party Estimate	-83.29%

7D Total Return	-3.62%
30D Total Return	-23.59%
YTD Total Return	-36.20%
1Y Total Return	-6.52%
3Y Total Return	+3112.28%
5Y Total Return	+38.68%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	-36.20%
2025	+116.66%
2024	+2418.88%
2023	-61.35%
2022	-76.66%
2021	N/A

CAGR TTM	-6.49%
CAGR 3Y	+217.80%
CAGR 5Y	+6.76%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

DRUG Valuation Metrics

DRUG Stock Price Metrics

DRUG Dividend Metrics

DRUG Growth Rate Metrics

DRUG Discounted Cash Flow Metrics

DRUG Returns By Period

DRUG Yearly Returns

DRUG Average Annual Returns By Period (CAGR)

DRUG Revenue Metrics

DRUG PE Ratio Metrics

DRUG PS Ratio Metrics

DRUG PB Ratio Metrics

DRUG Price to Free Cash Flow Ratio Metrics

DRUG Debt to Equity Ratio Metrics

DRUG PEG Ratio Metrics

DRUG FCF Yield

DRUG Earnings Yield

DRUG EBITDA Yield

DRUG OCF Yield

DRUG EV/EBIT Ratio Metrics

DRUG EV/EBITDA Ratio Metrics

DRUG EV/Assets Ratio Metrics

DRUG EV/Sales Ratio Metrics

DRUG Current Ratio Metrics

DRUG Quick Ratio Metrics

DRUG ROIC Metrics

DRUG Return on Assets Metrics

DRUG Return on Equity Metrics

DRUG Net Profit Margin Metrics

DRUG Gross Profit Margin Metrics

DRUG Tax Rate Metrics

PS Ratio	N/A
PS Ratio Avg TTM	N/A
PS Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

PB Ratio	2.26
PB Ratio Avg TTM	7.84
PB Ratio Avg 3Y	4.67
Current VS TTM Avg	-71.16%
Current VS 3Y Avg	-51.57%
Current VS 5Y Avg	-14.90%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.00
Debt/Equity Ratio Avg TTM	0.00
Debt/Equity Ratio Avg 3Y	0.00
Current VS TTM Avg	-81.97%
Current VS 3Y Avg	-95.13%
Current VS 5Y Avg	-95.96%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	1.25
Ev/Assets Ratio Avg TTM	6.72
Ev/Assets Ratio Avg 3Y	4.25
Current VS TTM Avg	-81.40%
Current VS 3Y Avg	-70.59%
Current VS 5Y Avg	-52.17%

Ev/Sales Ratio	N/A
Ev/Sales Ratio Avg TTM	N/A
Ev/Sales Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Current Ratio	121.97
Current Ratio Avg TTM	76.70
Current Ratio Avg 3Y	53.53
Current VS TTM Avg	+59.03%
Current VS 3Y Avg	+127.86%
Current VS 5Y Avg	+184.06%

Quick Ratio	121.97
Quick Ratio Avg TTM	76.70
Quick Ratio Avg 3Y	53.53
Current VS TTM Avg	+59.03%
Current VS 3Y Avg	+127.86%
Current VS 5Y Avg	+184.06%

ROIC	(13.15%)
ROIC Avg 3Y	(48.49%)
ROIC Avg 5Y	(70.92%)
Current VS 3Y Avg	+72.87%
Current VS 5Y Avg	+81.45%
Current VS 10Y Avg	+80.44%

ROA	(8.14%)
ROA Avg TTM	(5.47%)
ROA Avg 3Y	(8.78%)
Current VS TTM Avg	-48.81%
Current VS 3Y Avg	+7.33%
Current VS 5Y Avg	+44.76%

ROE	(8.21%)
ROE Avg TTM	(14.22%)
ROE Avg 3Y	(47.47%)
Current VS TTM Avg	+42.28%
Current VS 3Y Avg	+82.70%
Current VS 5Y Avg	+88.39%

Net Profit Margin	0.00%
Net Profit Margin Avg TTM	0.00%
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	0.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A